ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 137 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $685,000 | +84.1% | 48,058 | +8.3% | 0.12% | +68.6% |
| Q2 2017 | $372,000 | +22.8% | 44,385 | +31.2% | 0.07% | -1.4% |
| Q1 2017 | $303,000 | +203.0% | 33,839 | +43.3% | 0.07% | +136.7% |
| Q4 2015 | $100,000 | +37.0% | 23,609 | +47.8% | 0.03% | +20.0% |
| Q3 2015 | $73,000 | – | 15,976 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |